FDA Drug Application (072319) for GLYCOPREP by GOLDLINE

Back to FDA Applications sponsored by GOLDLINE

Application Number072319
Product Number001
FormFOR SUSPENSION;ORAL
Dosage236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameGLYCOPREP
Active IngredientPOLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS



Back to FDA Applications sponsored by GOLDLINE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.